International Journal of Cancer Management

Published by: Kowsar

Association of Systemic Anaplastic Large Cell Lymphoma and Active Toxoplasmosis in a Child

Shirin Sayyahfar 1 , Abdollah Karimi 2 , * , Atoosa Gharib 3 and Alireza Fahimzad 2
Authors Information
1 Department of Paediatrics, Ali Asghar Children Hospital, Iran University of Medical Sciences, Tehran, IR Iran
2 Paediatric Infection Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Department of Pathology, Imam Hosein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Iranian Journal of Cancer Prevention: August 28, 2015, 8 (4); e3438
  • Published Online: August 24, 2015
  • Article Type: Case Report
  • Received: July 6, 2015
  • Accepted: July 11, 2015
  • DOI: 10.17795/ijcp-3438

To Cite: Sayyahfar S, Karimi A, Gharib A, Fahimzad A. Association of Systemic Anaplastic Large Cell Lymphoma and Active Toxoplasmosis in a Child, Int J Cancer Manag. 2015 ; 8(4):e3438. doi: 10.17795/ijcp-3438.

Copyright © 2015, Iranian Journal of Cancer Prevention.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
4. Conclusions
  • 1. Tilly H, Gaulard P, Lepage E, Dumontet C, Diebold J, Plantier I, et al. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood. 1997; 90(9): 3727-34[PubMed]
  • 2. Le Deley MC, Reiter A, Williams D, Delsol G, Oschlies I, McCarthy K, et al. Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study. Blood. 2008; 111(3): 1560-6[DOI][PubMed]
  • 3. Lowe EJ, Sposto R, Perkins SL, Gross TG, Finlay J, Zwick D, et al. Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941. Pediatr Blood Cancer. 2009; 52(3): 335-9[DOI][PubMed]
  • 4. Jaffe ES, Harris NL, Stein H. World Health Organization Classification of Tumours: Pathology and genetics of Tumors of Haematopoettic and Lymphoid Tissues. 2001;
  • 5. Thirugnanam S, Rout N, Gnanasekar M. Possible role of Toxoplasma gondii in brain cancer through modulation of host microRNAs. Infectious Agents and Cancer. 2013; 8(1): 8[DOI]
  • 6. Stein H, Foss HD, Durkop H, Marafioti T, Delsol G, Pulford K, et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 2000; 96(12): 3681-95[PubMed]
  • 7. Greer JP. T Cell and NK Cell Lymphoproliferative Disorders. Hematol. 2001; 2001(1): 259-81[DOI]
  • 8. Kamiyama T. Toxoplasma-induced activities of peritoneal and spleen natural killer cells from beige mice against thymocytes and YAC-1 lymphoma targets. Infect Immun. 1984; 43(3): 973-80[PubMed]
  • 9. Kamiyama T, Tatsumi M. Effect of Toxoplasma infection on the sensitivity of mouse thymocytes to natural killer cells. Infect Immun. 1983; 42(2): 789-95[PubMed]
  • 10. Dudley NJ, Balfour AH. Non-Hodgkin's lymphoma presenting as 'chronic active toxoplasmosis'. Postgraduate Medical Journal. 1988; 64(757): 883-5[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments